Download PDF
Pharmacopsychiatry 2022; 55(02): e1
DOI: 10.1055/a-1737-1527
Erratum

Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

Authors

  • Jose de Leon 

    1   Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA
    2   Department of Psychiatry, University of Kentucky, Lexington, KY, USA
    3   Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain
    4   Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain

  • Georgios Schoretsanitis 

    5   Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland
    6   The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA

  • Robert L. Smith 

    7   Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway

  • Espen Molden 

    7   Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway
    8   Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway

  • Anssi Solismaa 

    9   Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
    10   Department of Psychiatry, Tampere University Hospital, Tampere, Finland

  • Niko Seppälä 

    11   Department of Psychiatry, Satasairaala, Finland

  • Miloslav Kopeček 

    12   National Institute of Mental Health, Klecany, Czech Republic
    13   Department of Psychiatry, Charles University, Third Faculty of Medicine, Prague, Czech Republic

  • Patrik Švancer 

    12   National Institute of Mental Health, Klecany, Czech Republic
    13   Department of Psychiatry, Charles University, Third Faculty of Medicine, Prague, Czech Republic

  • Ismael Olmos 

    14   Clinical Pharmacology Unit and Pharmacy Department, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay

  • Carina Ricciardi 

    15   Clinical Pharmacology Unit and Outpatient Clinic, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay

  • Celso Iglesias-Garcia 

    16   Universidad de Oviedo. CIBERSAM. INEUROPA. ISPA-FIMBA, Oviedo, Spain
    17   Hospital Valle del Nalón, Langreo, Spain

  • Ana Iglesias-Alonso 

    18   Hospital Universitario Central de Asturias, Oviedo, Spain

  • Edoardo Spina 

    19   Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

  • Can-Jun Ruan 

    20   Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China
    21   The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China

  • Chuan-Yue Wang 

    21   The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
    22   Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China

  • Gang Wang

    21   The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China

  • Yi-Lang Tang 

    23   Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA
    24   Substance Abuse Treatment Program, Atlanta VA Medical Center, Decatur, Georgia, USA

  • Shih-Ku Lin 

    25   Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
    26   Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan

  • Hsien-Yuan Lane 

    27   Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
    28   Department of Psychiatry and Brain Disease Research Center, China Medical University Hospital, Taichung, Taiwan
    29   Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan

  • Yong Sik Kim 

    30   Department of Neuropsychiatry, Nowon Eulji Medical Center, Eulji University, School of Medicine, Seoul, Korea

  • Se Hyun Kim 

    31   Department of Psychiatry, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea

  • Anto P. Rajkumar 

    32   Department of Psychiatry, Christian Medical College, Vellore, India
    33   Institute of Mental Health, Jubilee Campus, University of Nottingham, Triumph Road, Nottingham, United Kingdom

  • Dinora F. González-Esquivel 

    34   Instituto Nacional de Neurología y Neurocirugía, México City, México

  • Helgi Jung-Cook 

    34   Instituto Nacional de Neurología y Neurocirugía, México City, México
    35   Facultad de Química, Universidad Nacional Autónoma de México (UNAM), México City, México

  • Trino Baptista 

    36   Department of Physiology, Los Andes University Medical School, Mérida, Venezuela

  • Christopher Rohde 

    37   Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark
    38   Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

  • Jimmi Nielsen 

    39   Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark

  • Hélène Verdoux 

    40   Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France

  • Clelia Quiles 

    40   Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France

  • Emilio J. Sanz 

    41   Department of Physical Medicine and Pharmacology, School of Medicine, Universidad de La Laguna, Canary Islands, Spain
    42   Hospital Universitario de Canarias, Tenerife, Spain

  • Carlos De Las Cuevas 

    43   Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, and Instituto Universitario de Neurociencia (IUNE), University of La Laguna, Canary Islands, Spain

  • Dan Cohen 

    44   Dutch Clozapine Collaboration Group, Castricum, The Netherlands
    45   FACT-team in Heerhugowaard, Department of Severe Mental Illness, Mental Health Services North-Holland North, The Netherlands

  • Peter F.J. Schulte 

    44   Dutch Clozapine Collaboration Group, Castricum, The Netherlands
    46   Mental Health Team Alkmaar, Mental Health Services Noord-Holland-Noord, Alkmaar, The Netherlands

  • Aygün Ertuğrul 

    47   Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey

  • A. Elif Anıl Yağcıoğlu 

    47   Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey

  • Nitin Chopra 

    48   Addictions Division, Centre for Addiction and Mental Health, Toronto, Canada
    49   Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

  • Betsy McCollum 

    50   Eastern State Hospital, Lexington, Kentucky, USA

  • Charles Shelton 

    2   Department of Psychiatry, University of Kentucky, Lexington, KY, USA
    50   Eastern State Hospital, Lexington, Kentucky, USA

  • Robert O. Cotes 

    23   Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA

  • Arun R. Kaithi

    51   Hazelwood Center, Louisville, Kentucky, USA

  • John M. Kane 

    6   The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA
    52   Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, New York, USA

  • Saeed Farooq 

    53   School of Medicine, Keele University, Staffordshire, and Midlands Partnership NHS Foundation Trust, Staffordshire, United Kingdom

  • Chee H. Ng 

    54   Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia

  • John Bilbily 

    55   Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA

  • Christoph Hiemke 

    56   Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Germany

  • Carlos López-Jaramillo 

    57   Grupo de Investigación en Psiquiatría GIPSI, Departamento de Psiquiatría, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia
    58   Programa Trastornos del Ánimo, Hospital Universitario San Vicente Fundación, Medellín, Colombia

  • Ian McGrane 

    59   Department of Pharmacy Practice, University of Montana, Missoula, USA

  • Fernando Lana 

    60   Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona, Spain
    61   Department of Psychiatry, Autonomous University of Barcelona, Spain

  • Chin B. Eap 

    62   Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne, Switzerland
    63   Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Switzerland
    64   School of Pharmaceutical Sciences, University of Geneva, Switzerland
    65   Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Switzerland

  • Manuel Arrojo-Romero

    66   Department of Psychiatry, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain

  • Flavian Ş. Rădulescu

    67   Center for Drug Sciences, Faculty of Pharmacy, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania

  • Erich Seifritz

    5   Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland

  • Susanna Every-Palmer 

    68   Te Korowai Whāriki Central Regional Forensic Service, Capital and Coast District Health Board, Wellington, New Zealand
    69   Department of Psychological Medicine, University of Otago, Wellington, New Zealand

  • Chad A. Bousman 

    70   Departments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences University of Calgary, Alberta, Canada

  • Emmanuel Bebawi 

    71   Faculty of Medicine, University of Montreal, Montreal, Canada
    72   Department of Pharmacy, Hôpital du Sacré-Cœur de Montréal, Montreal, Canada

  • Rahul Bhattacharya 

    73   East London NHS Foundation Trust, London, United Kingdom
    74   Honorary Clinical Senior Lecturer, Barts and the London School of Medicine, Queen Mary University of London, United Kingdom

  • Deanna L. Kelly 

    75   Department of Psychiatry, School of Medicine, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland, USA

  • Yuji Otsuka 

    76   Department of Psychiatry, Asahi General Hospital, Chiba, Japan

  • Judit Lazary 

    77   National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary

  • Rafael Torres

    78   Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

  • Agustin Yecora

    79   Secretaría de Salud Mental y Adicciones, Ministerio de Salud de la Provincia de Jujuy, San Salvador de Jujuy, Argentina

  • Mariano Motuca 

    80   Instituto Vilapriño, Center for Studies, Assistance and Research in Neurosciences, Mendoza, Argentina

  • Sherry K.W. Chan 

    81   Department of Psychiatry, LSK Faculty of Medicine, The University of Hong Kong, Hong Kong SAR
    82   State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR

  • Monica Zolezzi 

    83   College of Pharmacy, QU Health, Qatar University, Doha, Qatar

  • Sami Ouanes 

    84   Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar

  • Domenico De Berardis 

    85   NHS, Department of Mental Health, “G. Mazzini” Hospital, Teramo, Italy

  • Sandeep Grover 

    86   Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India

  • Ric M. Procyshyn 

    87   British Columbia Mental Health and Substance Use Research Institute, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada

  • Richard A. Adebayo 

    88   Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria

  • Oleg O. Kirilochev 

    89   Department of Clinical Pharmacology, Astrakhan State Medical University, Astrakhan, Russian Federation

  • Andrey Soloviev 

    90   Department of Psychiatry and Clinical Psychology, Northern State Medical University, Arkhangelsk, Russia

  • Konstantinos N. Fountoulakis 

    91   3rd Department of Psychiatry, Division of Neurosciences, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece

  • Alina Wilkowska 

    92   Department of Psychiatry, Medical University of Gdańsk, Gdańsk, Poland

  • Wiesław J. Cubała 

    92   Department of Psychiatry, Medical University of Gdańsk, Gdańsk, Poland

  • Muhammad Ayub 

    93   Department of Psychiatry, Queens University, Kingston, Canada

  • Alzira Silva 

    94   Psychiatry Department, Centro Hospitalar Universitário de S. João, Porto, Portugal
    95    Faculdade de Medicina da Universidade do Porto, Porto, Portugal

  • Raphael M. Bonelli

    96    Sigmund Freud University, Vienna, Austria

  • José M. Villagrán-Moreno 

    97    Department of Neurosciences, Jerez University Hospital, Andalusian Health Service, University of Cadiz, Jerez, Spain

  • Benedicto Crespo-Facorro 

    98    Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain
    99    Spanish Network for Research in Mental Health (CIBERSAM), Sevilla, Spain

  • Henk Temmingh 

    100   Department of Psychiatry and Mental Health, University of Cape Town, Valkenberg Hospital, Western Cape, Cape Town, South Africa

  • Eric Decloedt 

    101   Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

  • Maria R. Pedro 

    102   Hospital Central de Maputo, Maputo, Mozambique

  • Hiroyoshi Takeuchi 

    103   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

  • Masaru Tsukahara 

    104   Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan

  • Gerhard Gründer 

    105   Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

  • Marina Sagud 

    106   Department of Psychiatry, School of Medicine, University of Zagreb, Zagreb, Croatia
    107   Department for Psychiatry and Psychological Medicine, University Hospital Center Zagreb, Croatia

  • Andreja Celofiga 

    108   Department of Psychiatry, University Medical Centre Maribor, Maribor, Slovenia

  • Dragana Ignjatovic Ristic 

    109   University of Kragujevac, Faculty of Medical Sciences, Department of Psychiatry, Kragujevac, Serbia

  • Bruno B. Ortiz 

    110   Group of Resistant Schizophrenia (GER), Schizophrenia Program (Proesq), Federal University of Sao Paulo, SP, Brazil

  • Helio Elkis 

    111   Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Sao Paulo, Brazil

  • António J. Pacheco Palha 

    112   Department and Institute of Psychiatry and Mental Health, Oporto Faculty of Medicine, Oporto, Portugal
    113   Casa de Salidedo Som Jesus (Psychiatric Hospital), Oporto, Portugal

  • Adrián LLerena 

    114   INUBE Biosanitary Research Institute of Extremadura. Extremadura University Hospital and Medical School, Badajoz, Spain
    115   Spanish Network for Research in Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain

  • Emilio Fernandez-Egea 

    116   Cambridge Psychosis Centre, Cambrigeshire and Peterborough NHS Foundation Trust & Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom

  • Dan Siskind 

    117   Metro South Addiction and Mental Health Service, Brisbane, Australia
    118   Queensland Centre for Mental Health Research and School of Clinical Medicine, University of Queensland, Brisbane, Australia

  • Abraham Weizman 

    119   Research Unit, Geha Mental Health Center and Molecular Psychiatry Laboratory, Felsenstein Medical Research Center, Tel Aviv, Israel
    120   Department of Psychiatry Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel

  • Rim Masmoudi 

    121   Psychiatry “A” Department, Hedi Chaker University Hospital, Sfax, Tunisia
    122   Faculty of Medicine, University of Sfax, Sfax, Tunisia

  • Shamin Mohd Saffian 

    123   Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

  • Jonathan G. Leung 

    124   Department of Pharmacy, Mayo Clinic, Rochester, MN, USA

  • Peter F. Buckley 

    125   School of Medicine, Virginia Commonwealth University, Richmond, VA, USA

  • Stephen R. Marder 

    126   Semel Institute for Neuroscience at UCLA, Los Angeles, CA, USA
    127   VA Desert Pacific Mental Illness Research, Education, and Clinical Center, Los Angeles, CA, USA

  • Leslie Citrome 

    128   New York Medical College, Department of Psychiatry and Behavioral Sciences, Valhalla, NY, USA

  • Oliver Freudenreich 

    129   Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

  • Christoph U. Correll 

    6   The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA
    52   Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, New York, USA
    130   Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany

  • Daniel J. Müller 

    48   Addictions Division, Centre for Addiction and Mental Health, Toronto, Canada
    49   Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Further Information
Also available at
 
 PDF Download Permissions and Reprints

Corrected by:

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsPharmacopsychiatry 2022; 55(02): 73-86
DOI: 10.1055/a-1625-6388

Erratum

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

References
de Leon J, Schoretsanitis G, Smith RL et al. Pharmacopsychiatry 2021

DOI: 10.1055/a-1625-6388

In the above-mentioned article, the spelling of 5 authors last names has been wrong and these names have been corrected.


 

 

Publication History

Article published online:
20 January 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

  Permissions and Reprints